Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma

J. Chou, Alexander; S. Kleinerman, Eugenie; Krailo, Mark; Chen, Zhengjia; L. Betcher, Donna; H. Healey, John; U. Conrad, Ernest; L. Nieder, Michael; A. Weiner, Michael; J. Wells, Robert; B. Womer, Richard; A. Meyers, Paul; behalf of the Children's Oncology Group, on

doi:10.1002/cncr.24566

Public

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma

Published in Cancer • Jul 28, 2009

Authors:

Alexander J. Chou

Eugenie S. Kleinerman

Mark Krailo

Abstract

BACKGROUND: The addition of liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) to chemotherapy has been shown to improve overall survival in patients with nonmetastatic osteosarcoma (OS). The authors report the results of addition of liposomal MTP-PE to chemotherapy for patients with met...

Subject

Medicine

Regimen

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!